Latest filing published 23 Aug 2018 for NextCell Pharma AB, €2,392.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Leo Cornelis Groenewegen: trading record in brief
Filings by Leo Cornelis Groenewegen span 2 companies, the busiest being NextCell Pharma and NextCell Pharma AB. We count 2 filings; the first trade dates from 27 December 2017 and the latest from 23 August 2018.
On the market, this insider has only ever bought: 1 purchase, €9,080 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 23 August 2018, reports a transaction of €2,392 in NextCell Pharma AB. The most recent open-market purchase was published on 28 December 2017, 3,237 days ago. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Leo Cornelis Groenewegen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,050 shares@ SEK 5.0029.4% of flowISIN SE0009723125FI:csv-d06cc08ceb861287fb8f
- 15,000 shares@ SEK 6.00100.0% of flowISIN SE0009723125FI:csv-1a2a0ee9674a1b5f612cCanonical exit: 27 Mar 2018 (T+90)
2 of 2 declarations